Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiad225 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Abhishek N Prasad und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA. Hauptthemen laut MEDLINE: Ebolavirus, Hemorrhagic Fever, Ebola. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
The primary route of infection by Ebola virus (EBOV) is through contact of mucosal surfaces. Few studies have explored infection of nonhuman primates (NHPs) via the oral mucosa, which is a probable portal of natural infection in humans.
Methods
To further characterize the pathogenesis of EBOV infection via the oral exposure route, we challenged cohorts of cynomolgus monkeys with low doses of EBOV variant Makona.
Results
Infection with 100 or 50 PFU of EBOV Makona via the oral route resulted in 50% and 83% lethality, respectively. Animals that progressed to fatal disease exhibited lymphopenia, marked coagulopathy, high viral loads, and increased levels of serum markers of inflammation and hepatic/renal injury. Survival in these cohorts was associated with milder fluctuations in leukocyte populations, lack of coagulopathy, and reduced or absent serum markers of inflammation and/or hepatic/renal function. Surprisingly, 2 surviving animals from the 100- and 50-PFU cohorts developed transient low-level viremia in the absence of other clinical signs of disease. Conversely, all animals in the 10 PFU cohort remained disease free and survived to the study end point.
Conclusions
Our observations highlight the susceptibility of NHPs, and by extension, likely humans, to relatively low doses of EBOV via the oral route.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
- Galveston National Laboratory, University of Texas Medical Branch, Galveston, Texas, USA.
ORCID-Profile: Abhishek N Prasad, Krystle N Agans, Courtney Woolsey, Thomas W Geisbert, Robert W Cross
Förderung
- NIEHS NIH HHS
- NIAID NIH HHS
- NIH HHS
- HHS
- Defense Threat Reduction Agency
- Department of Health and Human Services
- National Institutes of Health
Zitieren
APA
Prasad, A. N., Agans, K. N., Geisbert, J. B., Borisevich, V., Deer, D. J., Dobias, N. S., Comer, J. E., Woolsey, C., Fenton, K. A., Geisbert, T. W., & Cross, R. W. (2023). Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad225
Vancouver
Prasad AN, Agans KN, Geisbert JB, Borisevich V, Deer DJ, Dobias NS, et al. Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad225
BibTeX
@article{Prasad2023,
author = {Prasad, Abhishek N and Agans, Krystle N and Geisbert, Joan B and Borisevich, Viktoriya and Deer, Daniel J and Dobias, Natalie S and Comer, Jason E and Woolsey, Courtney and Fenton, Karla A and Geisbert, Thomas W and Cross, Robert W},
title = {Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiad225}
}
EUVIMED